fda warning bpc 157 peptide products New Details 157 FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA Moves to Reevaluate Several Peptides American Med Spa Association The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for